Cancer is Europe's second leading cause of death, expected to rank first by 2035, yet it receives only 7% of healthcare investment. Cases rose 60% from...
The EIB granted Amadix a €15M loan to advance AI-driven blood tests for early cancer detection. Funds will support product development, U.S. validation, and global expansion....
The Clara Campal Comprehensive Oncology Centre (HM Ciocc) leads cancer research in Madrid's private sector, with 144 trials recruiting and 374 active studies in 2024. Focused...
Oniria Therapeutics is a company dedicated to the development of precision drugs in the preclinical stage focused on the elimination of persistent tumor cells, which are...